News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

CARGO Therapeutics, Inc. (NASDAQ: CRGX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $37.00 price target on the stock.

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director [Yahoo! Finance]

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

CARGO Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]

CARGO Therapeutics to Participate in Upcoming Investor Conferences

3/21/2024

04:05 pm

CRGX

2.9%

BEAT

Form 424B3 CARGO Therapeutics, Inc.

Form S-1 CARGO Therapeutics, Inc.

Form 4 CARGO Therapeutics, Inc. For: Jun 04 Filed by: Dhingra Kapil

Form 4 CARGO Therapeutics, Inc. For: Jun 04 Filed by: Bassan Abraham

Form 4 CARGO Therapeutics, Inc. For: Jun 04 Filed by: Viswanadhan Krishnan

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}